SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-082765
Filing Date
2022-03-23
Accepted
2022-03-23 16:21:07
Documents
14
Period of Report
2022-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d274949d8k.htm   iXBRL 8-K 30437
2 EX-99.1 d274949dex991.htm EX-99.1 10559
6 GRAPHIC g274949dsp1.jpg GRAPHIC 4197
  Complete submission text file 0001193125-22-082765.txt   178933

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imgo-20220323.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgo-20220323_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgo-20220323_pre.xml EX-101.PRE 11703
8 EXTRACTED XBRL INSTANCE DOCUMENT d274949d8k_htm.xml XML 3484
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40604 | Film No.: 22763450
SIC: 2834 Pharmaceutical Preparations